Clinical significance of the cachexia index in patients with small cell lung cancer
Abstract Background Cancer cachexia worsens the treatment outcomes of patients with small-cell lung cancer (SCLC). However, no reliable biomarker of cancer cachexia is yet known. Methods We retrospectively evaluated male SCLC patients who received induction chemotherapy or concurrent chemoradiothera...
Main Authors: | Se-Il Go, Mi Jung Park, Gyeong-Won Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08300-x |
Similar Items
-
Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma
by: Se-Il Go, et al.
Published: (2020-05-01) -
Evaluation of cachexia in oral submucous fibrosis
by: Pooja Singh, et al.
Published: (2012-01-01) -
Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive‐stage disease small cell lung cancer: Results from a randomized controlled trial
by: Gyeong‐Won Lee, et al.
Published: (2020-01-01) -
Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
by: Nicole Ebner, et al.
Published: (2020-02-01) -
Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
by: Nicole Ebner, et al.
Published: (2019-02-01)